UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of IL-32 in Bacillus Calmette-Guérin (BCG)-induced trained immunity in infections caused by different Leishmania spp

Microbial pathogenesis, 2021-09, Vol.158, p.105088-105088, Article 105088

2021

Volltextzugriff (PDF)

Interleukin 32, inflammation and cancer

Pharmacology & therapeutics (Oxford), 2017-06, Vol.174, p.127-137

2017

Volltextzugriff (PDF)

Molecular interactions and functions of IL‐32

Journal of leukocyte biology, 2021-01, Vol.109 (1), p.143-159

2021

Volltextzugriff (PDF)

IL-32 and its paradoxical role in neoplasia

Critical reviews in oncology/hematology, 2023-06, Vol.186, p.104011-104011, Article 104011

2023

Volltextzugriff (PDF)

Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production

FEBS letters, 2013-11, Vol.587 (23), p.3776-3781

2013

Volltextzugriff (PDF)

IL-15 enhances the capacity of primary human macrophages to control Leishmania braziliensis infection by IL-32/vitamin D dependent and independent pathways

Parasitology international, 2020-06, Vol.76, p.102097-102097, Article 102097

2020

Volltextzugriff (PDF)

Plasma IL-10, IL-19 and IL-32 are potential biomarkers for adenovirus-induced severe pneumonia in pediatric patients

Future virology, 2023-07, Vol.18 (10), p.621-631

2023

Volltextzugriff (PDF)

Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis

Oncoimmunology, 2022-12, Vol.11 (1), p.2057837-2057837

2022

Volltextzugriff (PDF)

IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIV

The Journal of infectious diseases, 2024-05, Vol.229 (5), p.1277-1289

2024

Volltextzugriff (PDF)

IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B

Journal of allergy and clinical immunology, 2020-07, Vol.146 (1), p.156-168

2020

Volltextzugriff (PDF)

Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6

Cytokine (Philadelphia, Pa.), 2020-01, Vol.125, p.154832-154832, Article 154832

2020

Volltextzugriff (PDF)

PREGNANT WOMEN WITH COVID-19 AND PLACENTA ANGIOGENESIS

Polski merkuriusz lekarski, 2023, Vol.51 (5), p.441-447

2023

Volltextzugriff (PDF)

Vascular growth factors of the placenta, apoptosis of blood neutrophils in pregnant women with post-COVID syndrome

Reproduktivnaâ èndokrinologiâ, 2023-12 (70), p.23-26

2023

Volltextzugriff (PDF)

Folding expression of IL-32, IL-33 and TNF-α in Patient’s Co-infected with Hepatitis C Virus and Toxoplasmosis

Egyptian Journal of Veterinary Sciences, 2025-02, Vol.56 (2), p.289-298

2025

Volltextzugriff (PDF)

Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients

Cytokine (Philadelphia, Pa.), 2019-08, Vol.120, p.273-281

2019

Volltextzugriff (PDF)

Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome

Journal of neuroimmunology, 2022-04, Vol.365, p.577820-577820, Article 577820

2022

Volltextzugriff (PDF)

IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling

International immunopharmacology, 2024-11, Vol.141, p.112966, Article 112966

2024

Volltextzugriff (PDF)

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension

Arthritis research & therapy, 2020-06, Vol.22 (1), p.127-127, Article 127

2020

Volltextzugriff (PDF)

Interaction network mapping among IL-32 isoforms

Biochimie, 2014-06, Vol.101, p.248-251

2014

Volltextzugriff (PDF)

IL-32α-induced inflammation constitutes a link between obesity and colon cancer

Oncoimmunology, 2017-01, Vol.6 (7), p.e1328338-e1328338

2017

Volltextzugriff (PDF)

Molecular mechanism–driven new biomarkers and therapies for atopic dermatitis

Journal of allergy and clinical immunology, 2020-07, Vol.146 (1), p.72-73

2020

Volltextzugriff (PDF)

Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells

BioFactors (Oxford), 2024-03, Vol.50 (2), p.294-310

2024

Volltextzugriff (PDF)

Immunotherapeutic Potential of Interleukin-32 and Trained Immunity for Leishmaniasis Treatment

Trends in parasitology, 2021-02, Vol.37 (2), p.130-141

2021

Volltextzugriff (PDF)

Role of interleukin-32 in the pathogenesis of endometriosis: in vitro, human and transgenic mouse data

Human reproduction (Oxford), 2018-05, Vol.33 (5), p.807-816

2018

Volltextzugriff (PDF)

mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes

Journal of neuroinflammation, 2024-08, Vol.21 (1), p.198-15, Article 198

2024

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(115)

Publikationsform

Artikel
(125)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The role of IL-32 in Bacillus Calmette-Guérin (BCG)-induced trained immunity in infections caused by different Leishmania spp

Interleukin 32, inflammation and cancer

Molecular interactions and functions of IL‐32

IL-32 and its paradoxical role in neoplasia

Interleukin-32δ interacts with IL-32β and inhibits IL-32β-mediated IL-10 production

IL-15 enhances the capacity of primary human macrophages to control Leishmania braziliensis infection by IL-32/vitamin D dependent and independent pathways

Plasma IL-10, IL-19 and IL-32 are potential biomarkers for adenovirus-induced severe pneumonia in pediatric patients

Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis

IL-32 Drives the Differentiation of Cardiotropic CD4+ T Cells Carrying HIV DNA in People With HIV

IL-32γ suppressed atopic dermatitis through inhibition of miR-205 expression via inactivation of nuclear factor-kappa B

Serum levels of IL-32 in patients with type 2 diabetes mellitus and its relationship with TNF-α and IL-6

PREGNANT WOMEN WITH COVID-19 AND PLACENTA ANGIOGENESIS

Vascular growth factors of the placenta, apoptosis of blood neutrophils in pregnant women with post-COVID syndrome

Folding expression of IL-32, IL-33 and TNF-α in Patient’s Co-infected with Hepatitis C Virus and Toxoplasmosis

Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients

Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome

IL-32 aggravates metabolic disturbance in human nucleus pulposus cells by activating FAT4-mediated Hippo/YAP signaling

Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension

Interaction network mapping among IL-32 isoforms

IL-32α-induced inflammation constitutes a link between obesity and colon cancer

Molecular mechanism–driven new biomarkers and therapies for atopic dermatitis

Modulatory effects of point-mutated IL-32θ (A94V) on tumor progression in triple-negative breast cancer cells

Immunotherapeutic Potential of Interleukin-32 and Trained Immunity for Leishmaniasis Treatment

Role of interleukin-32 in the pathogenesis of endometriosis: in vitro, human and transgenic mouse data

mTOR activation induces endolysosomal remodeling and nonclassical secretion of IL-32 via exosomes in inflammatory reactive astrocytes

Aktive Filter

Suchergebnisse filtern